OBJECTIVE-Glucagon-like peptide-1 (GLP-1) increases intracellular Ca 2ϩ concentrations ([Ca 2ϩ ] i ), resulting in insulin secretion from pancreatic ␤-cells. The molecular mechanism(s) of the GLP-1-mediated regulation of [Ca 2ϩ ] i was investigated. 2ϩ ] i were measured in ␤-cells isolated from Cd38 ϩ/ϩ and Cd38 Ϫ/Ϫ mice. Calcium-mobilizing second messengers were identified by measuring levels of nicotinic acid adenine dinucleotide phosphate (NAADP) and cyclic ADP-ribose (ADPR), using a cyclic enzymatic assay. To locate NAADP-and cyclic ADPRproducing enzyme(s), cellular organelles were separated using the sucrose gradient method. [Ca 2ϩ ] i increase showed a cooperative Ca 2ϩ signal, i.e., an initial [Ca 2ϩ ] i rise mediated by the action of NAADP that was produced in acidic organelles and a subsequent long-lasting increase of [Ca 2ϩ ] i by the action of cyclic ADPR that was produced in plasma membranes and secretory granules. GLP-1 sequentially stimulated production of NAADP and cyclic ADPR in the organelles through protein kinase A and cAMP-regulated guanine nucleotide exchange factor II. Furthermore, the results showed that NAADP production from acidic organelles governed overall Ca 2ϩ signals, including insulin secretion by GLP-1, and that in addition to CD38, enzymes capable of synthesizing NAADP and/or cyclic ADPR were present in ␤-cells. These observations were supported by the study with Cd38 Ϫ/Ϫ ␤-cells, demonstrating production of NAADP, cyclic ADPR, and Ca 2ϩ signal with normal insulin secretion stimulated by GLP-1. 
RESULTS-A GLP-1-induced
] i increase showed a cooperative Ca 2ϩ signal, i.e., an initial [Ca 2ϩ ] i rise mediated by the action of NAADP that was produced in acidic organelles and a subsequent long-lasting increase of [Ca 2ϩ ] i by the action of cyclic ADPR that was produced in plasma membranes and secretory granules. GLP-1 sequentially stimulated production of NAADP and cyclic ADPR in the organelles through protein kinase A and cAMP-regulated guanine nucleotide exchange factor II. Furthermore, the results showed that NAADP production from acidic organelles governed overall Ca 2ϩ signals, including insulin secretion by GLP-1, and that in addition to CD38, enzymes capable of synthesizing NAADP and/or cyclic ADPR were present in ␤-cells. These observations were supported by the study with Cd38 Ϫ/Ϫ ␤-cells, demonstrating production of NAADP, cyclic ADPR, and Ca 2ϩ signal with normal insulin secretion stimulated by GLP-1. (1) (2) (3) (4) ). An elevation of blood glucose levels stimulates insulin secretion through a specialized pathway that requires mitochondrial ATP synthesis, which leads to the closure of ATP-sensitive K ϩ channels, cell depolarization, and Ca 2ϩ influx (5) . In addition, glucose-mediated elevation of [Ca 2ϩ ] i is also achieved through two Ca 2ϩ -releasing receptors in the endoplasmic reticulum (ER): receptor for inositol 1,4,5-trisphosphate (IP 3 ) stimulated by IP 3 /phospholipase C activation and ryanodine receptor activated by cyclic ADP-ribose (ADPR) (6, 7) . Recent studies (8, 9) have indicated that cyclic ADPR also induces Ca 2ϩ entry. An additional pathway for intracellular Ca 2ϩ release channel is the nicotinic acid adenine dinucleotide phosphate (NAADP)-sensitive receptor channel reportedly present in acidic lysosome-related granules (10) . The production of cyclic ADPR and NAADP is catalyzed by ADPR cyclases, including CD38 (11, 12) . Glucose-stimulated Ca 2ϩ mobilization and insulin secretion are elevated by CD38 overexpression (13) and reduced by knockout (14) . Low levels of CD38 expression have been observed in diabetic ␤-cells such as ob/ob mouse islets and RINm5F insulinoma cells with poor glucose-stimulated insulin production/release (15) . A recent study (16) has indicated that NAADP initiates and propagates Ca 2ϩ signals in response to insulin and is involved in insulin synthesis. Along the same lines, NAADP-sensitive Ca 2ϩ store-controlled Ca 2ϩ signaling and the production of NAADP by glucose stimulus in ␤-cells have also been demonstrated (17, 18) .
CONCLUSIONS-Our
Glucagon-like peptide-1 (GLP-1), a peptide hormone released from gut L-cells, is a physiologically important potentiator of glucose-induced insulin secretion (19, 20) . The peptide elevates intracellular cAMP concentrations and causes activation of protein kinase A (PKA) and cAMP-regulated guanine nucleotide exchange factor II (Epac) (21, 22) . Although these cAMP-binding proteins have been shown to play a role in GLP-1-mediated transient and sustained increase of [Ca 2ϩ ] i (23) , it remains to be clarified whether the increase of [Ca 2ϩ ] i is mediated through activation of Ca 2ϩ channels directly or through generation of Ca 2ϩ -mobilizing second messengers by the molecules PKA and Epac.
In this study, we examined the possibility that GLP-1 signaling activates ADPR cyclases/CD38 in the context of NAADP-and/or cyclic ADPR-mediated regulation of Ca 2ϩ signals and insulin secretion. Our results demonstrate that the GLP-1-induced Ca 2ϩ signal is mediated in a spatiotemporally different mode by both NAADP and cyclic ADPR, which are produced by as yet unidentified enzyme(s), and CD38. In particular, we demonstrate that the GLP-1-induced Ca 2ϩ signal is regulated in a concerted and sequential way by the second messengers NAADP and cyclic ADPR.
RESEARCH DESIGN AND METHODS
Drugs. Anti-mouse CD38 monoclonal antibody was obtained from eBioscience (San Diego, CA,). Dulbecco's modified Eagle's medium containing low glucose and antibiotics was from Life Technologies (Grand Island, NY). GLP-1 (7-36) amide was purchased from American Peptide Company (Vista, CA). A 125 I-insulin radioimmunoassay kit was from Linco Research (Charles, MO). Biolog Life Science (Bremen, Germany) provided 8-pCPT-2Ј-O-Me-cAMP and N 6 -benzoyl-cAMP. Recombinant nicotinic acid mononucleotide adenylyltransferase was a gift from Dr. Se Won Suh (Department of Chemistry, Seoul National University, Seoul, Korea) (24) . All other reagents were obtained from Sigma.
Animals. Cd38
Ϫ/Ϫ mice with genetic background ICR were inbred in the animal facility of Chonbuk National University Medical School. The generation and characterization of Cd38 Ϫ/Ϫ mice have been described previously (14) . All experimental animals used were under a protocol approved by the institutional animal care and use committee of the Chonbuk National University Medical School. Standard guidelines for laboratory animal care were followed (25) .
Preparation of islets. Pancreatic islets were isolated from Cd38
ϩ/ϩ and Cd38 Ϫ/Ϫ mice weighing 25-30 g using a collagenase method (14, 26) , with the exception of changing Krebs-Ringer buffer to Krebs-Ringer bicarbonate buffer (KRBB) (in millimoles per liter: 2 CaCl 2 , 2.8 glucose, 145 NaCl, 1.19 KCl, 2.54 MgCl 2 , 1.19 KH 2 PO 4 , 5 NaHCO 3 , and 20 HEPES, pH 7.3). Briefly, mouse pancreata were distended by infusion of KRBB containing 0.15 mg/ml type V collagenase through the bile duct. Islets were isolated, washed with KRBB, and stabilized by culturing in a humidified incubator (95% air, 5% CO 2 ) overnight at 37°C in low glucose (5 mmol/l), Dulbecco's modified Eagle's medium supplemented with 10% (vol/vol) fetal bovine serum, 100 units/ml penicillin G, and 100 g/ml streptomycin (culture media).
Complete methods, including a description of the procedures for measurement of [Ca 2ϩ ] i , measurement of intracellular cyclic ADPR and NAADP concentration, separation of organelles, reconstitution study, analysis of CD38 in organelles, and measurement of insulin, are provided in the online appendix (available at http://dx.doi.org/10.2337/db07-0443). Statistical analysis. Data represent means Ϯ SEM of at least three separate experiments. Statistical analysis was performed using Student's t test. A value of P Ͻ 0.05 was considered significant. (Fig. 1A) . In contrast, the addition of 12 mmol/l glucose increased [Ca 2ϩ ] i and [Ca 2ϩ ] i slowly decreased, but not to the basal level, and sustained (Fig. 1B) . At the sustained Ca 2ϩ levels, application of GLP-1 induced a rapid and large rise of [Ca 2ϩ ] i that was also sustained (Fig. 1B) . It should be noted here that our preliminary studies showed that at 2.8 mmol/l glucose, none of the molecules used in this study generated Ca 2ϩ signals (data not shown). To examine whether the GLP-1-induced Ca 2ϩ signal is mediated by cAMP, we utilized forskolin, an activator of adenylyl cyclase. Treatment of ␤-cells with forskolin produced an increase in the Ca 2ϩ signal similar to that observed with GLP-1 (Fig. 1C) . Next, we asked whether PKA and Epac mediate the GLP-1-induced Ca 2ϩ signal. As shown in Fig. 1D , (Fig. 1E) . Pretreatment of the cells with high concentrations of ryanodine, which is known to inhibit ryanodine receptor or a cyclic ADPR antagonistic analog 8-Br-cyclic ADPR, resulted in a significant inhibition of only the GLP-1-induced sustained Ca 2ϩ signal (Figs. 1F and G, respectively) . Xestospongin C, an IP 3 receptor inhibitor, did not show any effects on the GLP-1-induced Ca 2ϩ signal (Fig. 1H) . However, acetylcholineinduced Ca 2ϩ signaling, which was proved to be due to IP 3 production (27) , was blocked by the reagent (online appendix Fig. 2 ). The effects of various inhibitors on the initial and sustained Ca 2ϩ increases are summarized in Fig. 1I signaling, we thought NAADP would be an interesting candidate since it is one of the most potent Ca 2ϩ -releasing messengers found thus far (28, 29) . Therefore, we initially tested whether NAADP can be transported into ␤-cells when applied extracellularly because NAADP is known to be transported in certain cell types (30) . Figure 2A shows that NAADP was transported in a time-dependent manner and that the NAADP transport was Ca 2ϩ and glucose dependent and partially blocked by dipyridamole (Fig. 2B) . Interestingly, cyclic ADPR externally applied to ␤-cells was also similarly transported, except in a Ca 2ϩ -independent manner (online appendix Fig. 3 ). To rule out any possibility of the effect on purinoreceptors by extracellularly added NAADP, we also tested the effects of equimolar concentration of NAD and NADP under the same condition. However, we could not find any significant signals with even high concentration of the nucleotides (online appendix Fig. 4 ). Treatment of ␤-cells with exogenous NAADP elicited Ca 2ϩ signals in a bell-shaped concentration response, and the Ca 2ϩ signal peaked at a 50 nmol/l concentration of NAADP (Fig. 2C) . However, the NAADPinduced Ca 2ϩ signal was not observed in the presence of 2.8 mmol/l glucose or in the Ca 3A) . A similar result was also observed by treatment of the cells with glycylphenylalanine 2-naphthylamide (GPN), which selectively disrupts these organelles via osmotic lysis (data not shown). After treatment of ␤-cells with bafilomycin A1 (Fig. 3B) or GPN (Fig. 3C) , the increase of [Ca 2ϩ ] i mediated by GLP-1 or forskolin could not be found. High concentrations of NAADP prevented the induction of Ca 2ϩ signals mediated by GLP-1 or forskolin (Fig. 3D) . In contrast, cyclic ADPRmediated Ca 2ϩ increase was not blocked by the treatment of 10 mol/l NAADP (Fig. 3E) . The cyclic ADPR-mediated Ca 2ϩ increase was also not affected by the treatment with either bafilomycin A1 or GPN (online appendix Fig. 6 ). In addition, bafilomycin A1 and GPN blocked generation of Epac-or PKA-induced Ca 2ϩ signals but not depolarizationevoked Ca 2ϩ influx (Figs. 3F and G). High concentrations of NAADP also completely abolished the Epac-or PKAinduced Ca 2ϩ signals (Fig. 3H) . Together, these results show that NAADP acts as the initiator and propagator of the GLP-1-induced Ca 2ϩ signal. The effects of inhibitors on various stimulator-induced Ca 2ϩ increases are summarized in Fig. 3I . Acidic organelles play an essential role in insulin secretion mediated by GLP-1. We evaluated the effects of acidic organelles disturbing agents on the insulin secretion induced by 12 mmol/l glucose or GLP-1 signaling molecules. Bafilomycin A1 and concanamycin A, inhibitors of vacuolar H ϩ -ATPase, have been reported to inhibit glucose-induced insulin secretion by mouse islets (35) . The glucose-induced insulin secretions were not affected by GPN or bafilomycin A1 (Fig. 4A) or by concanamycin A (online appendix Fig. 7) . In contrast, however, pretreatment of the cells with GPN or bafilomycin A1 completely blocked GPL-1-, PKA-, or Epac-induced insulin secretion (Fig. 4A) . Indeed, treatment with NAADP resulted in enhancement of insulin secretion at high glucose concentrations only, which was abolished by GPN or bafilomycin A1 (Fig. 4B) . These results indicate that acidic organelles, which involve NAADP-mediated signaling and probably Ca 2ϩ release, play critical roles in GLP-1-induced insulin secretion but not in glucose-induced insulin secretion. signal, we examined kinetics of the production of these two Ca 2ϩ -mobilizing messengers in response to GLP-1. Treatment of islets with GLP-1 generated NAADP first and then cyclic ADPR, with a delay of ϳ10 s (Fig. 5A) , suggesting that the production of cyclic ADPR depends on the NAADP-induced initial Ca 2ϩ signal (Fig. 2D and F) . Moreover, treatment of islets with NAADP increased the formation of cyclic ADPR, which was dependent on the presence of extracellular Ca 2ϩ (Fig. 5B) . We tested whether the cyclic ADPR production would be stimulated by a general Ca 2ϩ signal. Ionomycin-induced Ca 2ϩ signals did not affect cyclic ADPR production (online appendix Fig. 8 ) as in lymphokine-activated killer cells (8) , indicating that NAADP-induced Ca 2ϩ signaling specifically produces cyclic ADPR, as in sea urchin eggs (36) . We next evaluated dependency of glucose and C a 2ϩ on the GLP-1-stimulated production of NAADP and cyclic ADPR. As shown in Fig. 5C , high glucose concentrations increased the levels of NAADP and cyclic ADPR compared with low glucose concentrations. Addition of GLP-1 in the presence of high glucose concentrations further increased the production of NAADP and cyclic ADPR by ϳ3-and 2.5-fold, respectively. GLP-1-mediated production of NAADP and cyclic ADPR was significantly lower in the presence of 2.8 mmol/l glucose or absence of extracellular Ca 2ϩ than that in the presence of high glucose and extracellular Ca (Fig. 5D) , suggesting that NAADP is formed in acidic organelles. These results also indicate that the formation of cyclic ADPR may depend on NAADP signaling. NAADP and cyclic ADPR are produced in different organelles via CD38 and non-CD38 ADPR cyclase. CD38 (transmembrane glycoprotein) is known to catalyze the synthesis of NAADP and cyclic ADPR (7, 11, 12) . However, it has not yet been clarified which organelles in the pancreatic ␤-cells are involved in the production of NAADP and cyclic ADPR. To address the question, we resolved cellular organelles into at least three parts: plasma membranes, lysosomes, and secretory granules (Fig. 6A) . NADase activity was detected in all three organelles; however, the lysosomes-containing fraction contained the highest NADase activity among the three fractions ( Fig. 6B and C) . To determine the presence of enzyme(s) other than CD38 in these compartments, CD38 in each fraction was immunoprecipitated with a CD38-specific antibody, and NADase activity in the precipitates and supernatants was further determined. CD38 activity was found mainly in the lysosome fraction and less in the plasma membrane fraction. However, in the supernatants from all fractions, significant levels of NADase activity were also observed consistently (Figs. 6B and C) , suggesting an existence of non-CD38 enzyme(s) in ␤-cells. 
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We next performed reconstitution studies to determine the production of NAADP and cyclic ADPR in the organelles isolated. The reconstitution study revealed that cyclic ADPR was produced in both plasma membraneand secretory granule-containing fractions (Fig. 6D) . Interestingly, CD38 was not detected in the fractions of secretory granules. On the other hand, the production of NAADP was observed only in fractions containing lysosomes (Fig. 6D) . Moreover, the effect of PKA or Epac activator on the production of NAADP and cyclic ADPR showed specificity for the organelles; both PKA and Epac stimulated the generation of NAADP in the lysosomes only (Fig. 6E) . Epac activated the cyclic ADPR production in both plasma membranes and secretory granules, and PKA stimulated the cyclic ADPR formation only in the plasma membranes (Fig. 6F) . These data indicate that activation of CD38/ADPR cyclase(s) by GLP-1 depends on their intracellular localization, where assembly of cognate signaling proteins such as PKA and Epac may be different.
Production of NAADP and cyclic ADPR in Cd38
؊/؊ islets is reduced in response to GLP-1 without alteration of insulin secretion. To further confirm the above observations that enzymes producing NAADP and/or cyclic ADPR exist in ␤-cells, ␤-cells isolated from CD38 knockout mice (Cd38 Ϫ/Ϫ ) and the littermates (Cd38 ϩ/ϩ ) were used. In the presence of 12 mmol/l glucose, GLP-1-mediated Ca 2ϩ signals in these ␤-cells were somewhat different. The early Ca 2ϩ increases were similar to each other; however, the late phase of Ca 2ϩ signals in Cd38 Ϫ/Ϫ ␤-cells was gradually decreased while the Ca 2ϩ signals in Cd38 ϩ/ϩ ␤-cells were sustained (Fig. 7A) . When the production of NAADP and cyclic ADPR was determined, no alterations in the levels of NAADP and cyclic ADPR were observed in the presence of 12 mmol/l glucose only. However, GLP-1-stimulated production of NAADP and cyclic ADPR in Cd38 Ϫ/Ϫ islets was substantially higher than that with glucose alone and significantly reduced compared with that in Cd38 ϩ/ϩ islets (Fig. 7B) . Insulin secretion of Cd38 Ϫ/Ϫ islets stimulated by glucose or GLP-1 was similar to that of Cd38 ϩ/ϩ islets (Fig. 7C) . These findings clearly demonstrate that ADPR cyclase(s)/ NAADP-producing enzyme(s) other than CD38 exists in ␤-cells.
DISCUSSION
In this study, we showed that GLP-1 elevates Ca 2ϩ via stimulation of NAADP and cyclic ADPR production and that NAADP-induced Ca 2ϩ mobilization from acidic stores contributes to the GLP-1-stimulated Ca 2ϩ signal. The action of GLP-1 is complex, with multiple kinetic components shaping the Ca 2ϩ response. Our results firmly established a role of thapsigargin-and ryanodine-sensitive stores and also provide new data implicating a source of Ca 2ϩ in acidic organelles. Many equivocal results have been reported (9,13,14) on the possible role of CD38 and/or cyclic ADPR in glucose signaling in ␤-cells. Our results showed that high glucose concentrations alone could elevate cyclic ADPR and NAADP levels (Fig. 5C ). Consistent with our observations, Masgrau et al. (17) showed that high glucose levels (20 mmol/l) increase NAADP levels in MIN6 cells, a clonal pancreatic ␤-cell line. However, the glucose-induced production of NAADP and cyclic ADPR was not altered in Cd38 Ϫ/Ϫ islets compared with that in Cd38 ϩ/ϩ islets (Fig.  7B) . These findings together with immunoprecipitation (Figs. 6B and C) and reconstitution studies (Fig. 6D) suggest that additional ADPR cyclase(s) and/or NAADPproducing enzyme(s) besides CD38 exist in islets. Recently, an existence of enzymes capable of generating NAADP and/or cyclic ADPR beside CD38 has been reported in various tissues (37) .
Interestingly, at low concentrations of glucose (2.8 mmol/l), none of the following molecules generate Ca 2ϩ signals in ␤-cells: GLP-1, forskolin, activators of PKA and Epac, and NAADP. These molecules generate Ca 2ϩ signals only under the condition of high glucose-induced elevated basal Ca 2ϩ level (Fig. 1B) . In agreement with our observations, several studies have also reported that GLP-1 has no significant effects on ␤-cells at low concentrations of glucose (38, 39) . However, the reasons for the insensitivity of GLP-1 and other downstream signaling molecules at low concentrations of glucose remain completely unknown. Intriguingly, KCl-induced Ca 2ϩ signals could not substitute for the effect of high glucose concentrations in triggering GLP-1-induced Ca 2ϩ signals (online appendix Fig. 9 ). Glucose-induced Ca 2ϩ signals as well as metabolites of glucose may coordinate the cognate signaling molecules and/or organelles for the effective responses to subsequent stimuli in ␤-cells. 
GLP-1-INDUCED PRODUCTION OF Ca 2؉ MESSENGERS
In the present study, exogenous NAADP could be a useful tool for analyzing NAADP-mediated Ca 2ϩ signaling by virtue of the property of NAADP transport into ␤-cells. The characteristics of NAADP transport were very similar to those observed in RBL-2H3 cells, which were originally observed (30) . However, the exact mechanisms involved in the transport of NAADP in pancreatic islets remain to be clarified. Dependencies of the NAADP transport on high glucose and external Ca 2ϩ are the important issues to be solved in conjunction with the Ca 2ϩ signals in ␤-cells. Our data (Fig. 1E) , which represents sustained Ca 2ϩ (online appendix Fig. 6 ), while completely blocking the NAADPinduced Ca 2ϩ , which represents transient Ca 2ϩ (Fig. 3A) . Mitchell et al. (34) showed that NAADP decreased free Ca 2ϩ concentrations of dense-core secretory vesicles in permeabilized MIN6 ␤-cells. Duman et al. (41) reported also that dense-core secretory granules comprise a GPNsensitive acidic Ca 2ϩ store. Our results also showed a similar result in that 50 mol/l GPN released Ca 2ϩ from secretory granule-containing fractions and lysosome-containing fractions (online appendix Fig. 10) 2) thapsigargin resulted in a complete abolishment of the insulin-mediated Ca 2ϩ signals, while the agent inhibited the late phase of GLP-1-induced Ca 2ϩ signals but not the initial Ca 2ϩ spike (Fig. 1E) . Indeed, stimulation of mouse ␤-cells with 200 nmol/l insulin under the same conditions used by Johnson and Misler did not affect NAADP levels (online appendix Fig. 11 ). fraction (F, Origin) . Localization of CD38 was assessed by measuring NADase activity of CD38 immunoprecipitate of each fraction (‚, CD38 Abs). Control immunoprecipitates using anti-mouse IgG were measured for NADase activity (E, Control Abs). Unbound NADase activity was determined by measurement of NADase activity in the supernatant (f). D: Production of NAADP and cyclic ADPR in organelles. Each fraction was reconstituted with the lysate prepared from islets stimulated with 10 nmol/l GLP-1. NAADP and cyclic ADPR levels were determined. E: Epac-and PKA-mediated NAADP production in orgarnelles. F: Epac-and PKA-mediated cyclic ADPR in organelles. Each fraction was reconstituted with equal amount of the lysate prepared from islets that were stimulated with Epac or PKA activator. The production of NAADP and cyclic ADPR was measured as described above. Data represent means ؎ SE from three independent experiments. ‚, Epac-specific activator; E, PKA-specific activator. 
GLP-1-INDUCED PRODUCTION OF
